Knowledge Hub

Hand, Foot And Mouth Disease - Pipeline Review, H1 2016

Press Release   •   Oct 28, 2016 05:07 EDT

MarketResearchReports.biz has recently announced the addition of a market study “ Hand, Foot And Mouth Disease - Pipeline Review, H1 2016 ”, is a comparative analysis of the global market.

Hand, Foot And Mouth Disease - Pipeline Review, H1 2016

Summary

Global Markets Directs, Hand, Foot And Mouth Disease - Pipeline Review, H1 2016, provides an overview of the Hand, Foot And Mouth Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hand, Foot And Mouth Disease , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hand, Foot And Mouth Disease and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/742825

Scope

- The report provides a snapshot of the global therapeutic landscape of Hand, Foot And Mouth Disease

- The report reviews pipeline therapeutics for Hand, Foot And Mouth Disease by companies and universities/research institutes based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved Hand, Foot And Mouth Disease therapeutics and enlists all their major and minor projects

- The report assesses Hand, Foot And Mouth Disease therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news related to pipeline therapeutics for Hand, Foot And Mouth Disease

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Hand, Foot And Mouth Disease

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Hand, Foot And Mouth Disease pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table Of Content

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Hand, Foot And Mouth Disease Overview 6

Therapeutics Development 7

Pipeline Products for Hand, Foot And Mouth Disease - Overview 7

Pipeline Products for Hand, Foot And Mouth Disease - Comparative Analysis 8

Hand, Foot And Mouth Disease - Therapeutics under Development by Companies 9

Hand, Foot And Mouth Disease - Therapeutics under Investigation by Universities/Institutes 10

Hand, Foot And Mouth Disease - Pipeline Products Glance 11

Clinical Stage Products 11

Early Stage Products 12

Hand, Foot And Mouth Disease - Products under Development by Companies 13

Hand, Foot And Mouth Disease - Products under Investigation by Universities/Institutes 14

Hand, Foot And Mouth Disease - Companies Involved in Therapeutics Development 15

CJ HealthCare Corp. 15

Sentinext Therapeutics Sdn Bhd 16

Takeda Pharmaceutical Company Limited 17

Hand, Foot And Mouth Disease - Therapeutics Assessment 18

Assessment by Monotherapy Products 18

Assessment by Combination Products 19

Assessment by Route of Administration 20

Assessment by Molecule Type 21

Drug Profiles 23

(coxsackievirus [serotype A16] + Enterovirus [serotype 71]) vaccine - Drug Profile 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

CJ-40010 - Drug Profile 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

D-5 - Drug Profile 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

Enterovirus [serotype EV-A71] (virus like particle, bivalent) vaccine - Drug Profile 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

hand, foot and mouth disease (viral like particle, bivalent) vaccine - Drug Profile 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

TAK-021 - Drug Profile 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

Hand, Foot And Mouth Disease - Recent Pipeline Updates 29

Hand, Foot And Mouth Disease - Dormant Projects 30

Hand, Foot And Mouth Disease - Product Development Milestones 31

Featured News & Press Releases 31

Mar 11, 2012: Inviragen Reports Top-Line Results From Phase I Trial Of INV21 Vaccine For Treatment Of Hand, Foot And Mouth Disease 31

Appendix 32

Methodology 32

Coverage 32

Secondary Research 32

Primary Research 32

Expert Panel Validation 32

Contact Us 32

Disclaimer 33